Nature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
and is provided in this format here as a response to the exceptional public-health crisis. This accepted manuscript will continue through the processes of copy editing and formatting to publication of a finalized version of record on nature.com. Please note there may be errors present in this version, which may affect the content, and all legal disclaimers apply.
The severe acute respiratory syndrome coronavirus 2 epidemic in southern Africa has been characterised by three distinct waves. The first was associated with a mix of SARS-CoV-2 lineages, whilst the second and third waves were driven by the Beta and Delta variants, respectively. In November 2021, genomic surveillance teams in South Africa and Botswana detected a new SARS-CoV-2 variant associated with a rapid resurgence of infections in Gauteng Province, South Africa.
Norge Siste Nytt, Norge Overskrifter
Similar News:Du kan også lese nyheter som ligner på denne som vi har samlet inn fra andre nyhetskilder.
Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern AfricaNature research paper: Rapid epidemic expansion of the SARS-CoV-2 Omicron variant in southern Africa
Les mer »
Activity of convalescent and vaccine serum against SARS-CoV-2 OmicronA Nature research paper reports reduced effectiveness of vaccine- or infection-elicited antibodies against the SARS-CoV-2 Omicon variant, relative to other viral lineages
Les mer »
Look familiar? How rapid tests changed the pandemicLateral flow tests are now part of UK life, with billions spent on test kits. Has it been worth it?
Les mer »
Why are rapid tests for COVID-19 in such short supply?Given that the U.S. has been experiencing COVID waves for nearly two years, you may be wondering: How did we find ourselves in this situation? Public health experts explain the roots of the shortfall and what might be done to avoid one next time.
Les mer »